Domača stranRGEN • NASDAQ
add
Repligen Corp
Prejšnji trg. dan.
132,87 $
Dnevni razpon
132,26 $ - 135,30 $
Letni razpon
102,97 $ - 182,52 $
Tržna kapitalizacija
7,52 mrd. USD
Povprečni obseg
821,23 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
NASDAQ
V novicah
Vizitka
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden. Wikipedia
Generalni direktor
Datum ustanovitve
1981
Sedež organizacije
Spletno mesto
Zaposleni
1.778